人源化小鼠模型市场按类型、应用、技术、最终用户和地区划分

人源化小鼠模型市场规模预计在 2025 年达到 1.385 亿美元，预计在 2032 年达到 2.068 亿美元，2025 年至 2032 年的复合年增长率为 5.9%。

全球人源化小鼠模型市场是生物技术和药物研究生态系统中的关键领域，是推动药物发现、开发和治疗方法检验过程的重要工具。人源化小鼠模型是经过基因工程改造的实验室小鼠，拥有功能性人类基因、细胞、组织和器官，与传统囓齿动物模型相比，它建构了一个复杂的体内平台，能够更准确地重现人类的生物系统。

这些创新研究工具使研究人员能够在受控的实验室环境中研究人类特异性疾病、免疫反应和药物代谢模式，从而弥合了临床前研究与人体临床试验之间的转化差距。该市场提供各种类型的人源化模型，包括免疫人源化小鼠、肝臟人源化小鼠和肿瘤人源化小鼠，每种模型都旨在满足感染疾病、免疫学、传染病和个人化医疗中的特定研究需求。现代治疗方法日益复杂，尤其是在免疫疗法、基因疗法和精准医疗等领域，大大增加了对这些专门研究模型的需求。这是因为这些模型提供了卓越的预测能力并降低了药物开发平臺中的损耗率，最终有助于更有效率、更具成本效益的药物研究方法。

市场动态

全球人源化小鼠模型市场受到多种强劲驱动因素的驱动，这些因素推动了其强劲的成长轨迹。这主要源于对更具预测性的临床前模型的需求日益增长，这些模型能够更好地将研究成果转化为人体应用，从而降低临床试验中观察到的高失败率，并最大限度地减少后期药物开发失败带来的重大财务损失。癌症、自体免疫疾病和感染疾病的全球流行，推动了对能够模拟复杂人体病理生理的先进研究工具的需求。同时，精准医疗和个人化治疗的快速发展，使得能够准确代表个别患者反应和基因变异的人源化模型的使用成为必要。

此外，美国FDA 和 EMA 等监管机构对全面临床前测试的严格要求，加上透过更有效率和可预测的模型减少动物测试的日益重视，进一步加速了市场采用。然而，市场面临重大限制，包括与开发、维护和使用人源化小鼠模型相关的极高成本，每隻动物的成本可能从数百美元到数千美元不等，这构成了重大的财务障碍，特别是对于较小的研究机构和生物技术公司而言。

模型开发、维护和资料解读所需的复杂技术专长带来了额外的挑战，而能够使用这些先进研究工具的专业设施和训练有素的人员有限也带来了额外的挑战。此外，围绕基因改造和动物福利的伦理问题，以及监管基因改造生物使用的严格框架，可能会阻碍市场的成长和可及性。儘管有这些挑战，但由于新冠疫情和大流行防范研究等领域的新兴应用，市场仍呈现出巨大的机会，在这些领域，人源化模型已被证明对研究病毒发病机制和疫苗开发非常有用。此外，在製药公司和政府津贴机构加大对先进研究基础设施和合作研究计划的投资支持下，免疫疗法和CAR-T细胞疗法领域的扩张正在为市场扩张开闢新的机会。

本次调查的主要特点

• 本报告对全球人源化小鼠模型市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并说明了针对该市场的引人注目的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，对全球人源化小鼠模型市场的主要企业进行了概述。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过全球人源化小鼠模型市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 全球人源化小鼠模型市场（按类型），2020-2032

• 介绍
• 基因人源化小鼠模型
• 基于细胞的人源化小鼠模型

5. 全球人源化小鼠模型市场（依应用划分），2020 年至 2032 年

• 介绍
• 肿瘤学
• 免疫学
• 神经科学
• 感染疾病
• 毒理学
• 造血
• 其他（自体免疫疾病）

6. 全球人源化小鼠模型市场（依技术划分），2020 年至 2032 年

• 介绍
• CRISPR 或 Cas9 基因编辑
• RNA干扰（RNAi）
• 基因工程
• 胚胎干细胞模型
• 其他（利用慢病毒载体进行基因转殖）

7. 全球人源化小鼠模型市场（依最终用户划分），2020 年至 2032 年

• 介绍
• 製药和生物技术公司
• 合约研究组织
• 学术研究机构
• 其他（政府和非营利组织）

8. 2020 年至 2032 年全球人源化小鼠模型市场价值

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第九章 竞争态势

• The Jackson Laboratory
• Charles River Laboratories
• Champion Oncology Inc
• Taconic Biosciences Inc
• genOway SA
• BioDuro
• Creative Biolabs.
• Altogen Labs
• Lonza
• Ingenious Targeting Laboratory Inc
• TransCure bioServices
• Pharmatest Services Ltd
• Crown Bioscience

第 10 章分析师建议

• 机会
• 一致的机会地图

第 11 章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Humanized Mouse Model Market is estimated to be valued at USD 138.5 Mn in 2025 and is expected to reach USD 206.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

The global humanized mouse model market represents a critical segment within the biotechnology and pharmaceutical research ecosystem, serving as an indispensable tool for advancing drug discovery, development, and therapeutic validation processes. Humanized mouse models are genetically engineered laboratory mice that carry functional human genes, cells, tissues, or organs, thereby creating sophisticated in vivo platforms that more accurately recapitulate human biological systems compared to traditional rodent models.

These innovative research tools bridge the translational gap between preclinical studies and human clinical trials by providing researchers with the ability to study human-specific diseases, immune responses, and drug metabolism patterns within a controlled laboratory environment. The market encompasses various types of humanized models, including immune system humanized mice, liver humanized mice, and tumor humanized mice, each designed to address specific research requirements across oncology, immunology, infectious diseases, and personalized medicine applications. The increasing complexity of modern therapeutics, particularly in areas such as immunotherapy, gene therapy, and precision medicine, has significantly elevated the demand for these specialized research models, as they offer superior predictive capabilities and reduced attrition rates in drug development pipelines, ultimately contributing to more efficient and cost-effective pharmaceutical research processes.

Market Dynamics

The global humanized mouse model market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, primarily anchored by the escalating demand for more predictive preclinical models that can better translate research findings to human applications, thereby reducing the high failure rates observed in clinical trials and minimizing the substantial financial losses associated with late-stage drug development failures. The increasing prevalence of cancer, autoimmune diseases, and infectious diseases worldwide has intensified the need for sophisticated research tools capable of modeling complex human pathophysiology, while the rapid advancement of precision medicine and personalized therapeutics necessitates the use of humanized models that can accurately represent individual patient responses and genetic variations.

Additionally, stringent regulatory requirements imposed by agencies such as the U.S. FDA and EMA for comprehensive preclinical testing, coupled with the growing emphasis on reducing animal testing through more efficient and predictive models, has further accelerated market adoption. However, the market faces significant restraints including the exceptionally high costs associated with developing, maintaining, and utilizing humanized mouse models, which can range from hundreds to thousands of dollars per animal, creating substantial financial barriers particularly for smaller research institutions and biotechnology companies.

The complex technical expertise required for model development, maintenance, and data interpretation presents additional challenges, as does the limited availability of specialized facilities and trained personnel capable of handling these sophisticated research tools. Furthermore, ethical concerns surrounding genetic modification and animal welfare, along with stringent regulatory frameworks governing the use of genetically modified organisms, can impede market growth and accessibility. Despite these challenges, the market presents substantial opportunities driven by emerging applications in areas such as COVID-19 and pandemic preparedness research, where humanized models prove invaluable for studying viral pathogenesis and vaccine development, while the expanding field of immunotherapy and CAR-T cell therapy creates new avenues for market expansion, supported by increasing investments from pharmaceutical companies and government funding agencies in advanced research infrastructure and collaborative research initiatives.

Key Features of the Study

• This report provides in-depth analysis of the global humanized mouse model market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global humanized mouse model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include The Jackson Laboratory, Charles River Laboratories, Champion Oncology Inc, Taconic Biosciences Inc, genOway SA, BioDuro, Creative Biolabs., Altogen Labs, Lonza, Ingenious Targeting Laboratory Inc, TransCure bioServices, Pharmatest Services Ltd, and Crown Bioscience
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global humanized mouse model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global humanized mouse model market

Market Segmentation

• Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Genetic Humanized Mouse Models
  • Cell-Based Humanized Mouse Models
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Oncology
  • Immunology
  • Neuroscience
  • Infectious Diseases
  • Toxicology
  • Hematopoiesis
  • Others (Autoimmune Diseases)
• Technology Insights (Revenue, USD Mn, 2020 - 2032)
  • CRISPR or Cas9 Gene Editing
  • RNA Interference (RNAi)
  • Transgenic Technology
  • Embryonic Stem Cell-Based Models
  • Others (Lentiviral Vector-Mediated Gene Transfer)
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic and Research Institutions
  • Others (Government and Non-Profit Organizations)
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • The Jackson Laboratory
  • Charles River Laboratories
  • Champion Oncology Inc
  • Taconic Biosciences Inc
  • genOway SA
  • BioDuro
  • Creative Biolabs.
  • Altogen Labs
  • Lonza
  • Ingenious Targeting Laboratory Inc
  • TransCure bioServices
  • Pharmatest Services Ltd
  • Crown Bioscience

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Humanized Mouse Model Market, By Type
  • Global Humanized Mouse Model Market, By Application
  • Global Humanized Mouse Model Market, By Technology
  • Global Humanized Mouse Model Market, By End User
  • Global Humanized Mouse Model Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Humanized Mouse Model Market, By Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Genetic Humanized Mouse Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cell-Based Humanized Mouse Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Humanized Mouse Model Market, By Application, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Neuroscience
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Toxicology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hematopoiesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Autoimmune Diseases)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Humanized Mouse Model Market, By Technology, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• CRISPR or Cas9 Gene Editing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• RNA Interference (RNAi)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Transgenic Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Embryonic Stem Cell-Based Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Lentiviral Vector-Mediated Gene Transfer)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Humanized Mouse Model Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Government and Non-Profit Organizations)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Humanized Mouse Model Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• The Jackson Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Champion Oncology Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Taconic Biosciences Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• genOway SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioDuro
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Creative Biolabs.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Altogen Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lonza
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ingenious Targeting Laboratory Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• TransCure bioServices
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pharmatest Services Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Crown Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us